Machine-learning models could help drug firms remove viral contaminants from products more effectively as long as they have access to high-quality training data, say biomanufacturing researchers.

To ensure product and personal safety, highly skilled and dedicated experts working with SARS-CoV-2 and developing treatment options for COVID-19 must wear overalls, double gloves, sleeves, filtering ...